<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
         xmlns:dc="http://purl.org/dc/elements/1.1/"
         xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
         xmlns="http://purl.org/rss/1.0/">




    



<channel rdf:about="http://www.mmci-communications.org/media-and-news/statements/statements/RSS">
  <title>Press Statements</title>
  <link>http://www.mmci-communications.org</link>
  
  <description>
    
       
       
  </description>
  
  
  
            <syn:updatePeriod>daily</syn:updatePeriod>
            <syn:updateFrequency>1</syn:updateFrequency>
            <syn:updateBase>2008-07-22T12:59:54Z</syn:updateBase>
        
  
  <image rdf:resource="http://www.mmci-communications.org/logo.jpg"/>

  <items>
    <rdf:Seq>
        
            <rdf:li rdf:resource="http://www.mmci-communications.org/media-and-news/news-archives/media-archives-2010/april-2010/statement-hiv-prevention-research-focus-of-international-microbicides-conference-may-22-25"/>
        
        
            <rdf:li rdf:resource="http://www.mmci-communications.org/media-and-news/news-archives/media-archives-2009/february-2009/news_item.2009-02-25.4490969349"/>
        
        
            <rdf:li rdf:resource="http://www.mmci-communications.org/media-and-news/news-archives/media-archives-2009/february-2009/news_item.2009-02-10.7373312358"/>
        
        
            <rdf:li rdf:resource="http://www.mmci-communications.org/media-and-news/news-archives/2008/december-2008/news_item.2008-12-17.0656802414"/>
        
        
            <rdf:li rdf:resource="http://www.mmci-communications.org/media-and-news/news-archives/2008/november-2008/news_item.2008-11-07.1262148442"/>
        
        
            <rdf:li rdf:resource="http://www.mmci-communications.org/media-and-news/news-archives/2008/september-2008/statement-conrad-receives-100-million-from-usaid-for-microbicide-development.html"/>
        
        
            <rdf:li rdf:resource="http://www.mmci-communications.org/media-and-news/news-archives/2008/august-2008/news_item.2008-11-14.5538548057"/>
        
        
            <rdf:li rdf:resource="http://www.mmci-communications.org/media-and-news/news-archives/2008/february-2008/inaugural-omololu-falobi-awards-for-excellence-in-hiv-prevention.html"/>
        
        
            <rdf:li rdf:resource="http://www.mmci-communications.org/media-and-news/news-archives/2008/june-2008/trial-is-first-to-see-if-hiv-prevention-gels-are-safe-for-pregnant-women-their-babies.html"/>
        
        
            <rdf:li rdf:resource="http://www.mmci-communications.org/media-and-news/news-archives/2008/may-2008/statement-on-co-enrollment-of-participants-in-caprisa-004-and-hptn-035-in-south-africa.html"/>
        
    </rdf:Seq>
  </items>

</channel>

    <item rdf:about="http://www.mmci-communications.org/media-and-news/news-archives/media-archives-2010/april-2010/statement-hiv-prevention-research-focus-of-international-microbicides-conference-may-22-25">        <title>STATEMENT: HIV prevention research focus of International Microbicides Conference May 22-25</title>        <link>http://www.mmci-communications.org/media-and-news/news-archives/media-archives-2010/april-2010/statement-hiv-prevention-research-focus-of-international-microbicides-conference-may-22-25</link>        <description>(Eurekalert!, Pittsburgh, PA) 14 April 14 2010: HIV prevention researchers, policy makers and community advocates from more than 35 countries will be in Pittsburgh, May 22-25 to attend the 2010 International Microbicides Conference (M2010).</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>Karel</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Statement</dc:subject>                <dc:date>2010-06-04T09:34:03Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.mmci-communications.org/media-and-news/news-archives/media-archives-2009/february-2009/news_item.2009-02-25.4490969349">        <title>STATEMENT: International Partnership for Microbicides Receives US $130 Million from UK Government and the Gates Foundation</title>        <link>http://www.mmci-communications.org/media-and-news/news-archives/media-archives-2009/february-2009/news_item.2009-02-25.4490969349</link>        <description>(IPM, Silver Springs, Md.) 24 February 2009: New support will accelerate development of new tools to help women protect themselves from HIV</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>Deborah</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>International Partnership for Microbicides</dc:subject>                    <dc:subject>Funding</dc:subject>                    <dc:subject>Statement</dc:subject>                    <dc:subject>IPM</dc:subject>                <dc:date>2009-02-25T12:09:08Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.mmci-communications.org/media-and-news/news-archives/media-archives-2009/february-2009/news_item.2009-02-10.7373312358">        <title>STATEMENT: Indevus pharmaceuticals announces PRO 2000 found to show promise in large HIV prevention study </title>        <link>http://www.mmci-communications.org/media-and-news/news-archives/media-archives-2009/february-2009/news_item.2009-02-10.7373312358</link>        <description>By PR Newswire (Indevus) 9 February 2009: Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced today that a National Institutes of Health (NIH)-sponsored clinical study found that participating women who received PRO 2000, the Company's candidate vaginal microbicide for HIV prevention, had an approximately 30% lower risk of acquiring HIV infection than women who received a placebo or no vaginal product.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>Mialy</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>PRO2000</dc:subject>                    <dc:subject>South Africa</dc:subject>                    <dc:subject>Trial</dc:subject>                    <dc:subject>MTN</dc:subject>                    <dc:subject>Statement</dc:subject>                    <dc:subject>CAPRISA</dc:subject>                <dc:date>2009-02-23T13:02:38Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.mmci-communications.org/media-and-news/news-archives/2008/december-2008/news_item.2008-12-17.0656802414">        <title>STATEMENT: Researchers discover new way men can transmit HIV to women</title>        <link>http://www.mmci-communications.org/media-and-news/news-archives/2008/december-2008/news_item.2008-12-17.0656802414</link>        <description>Eurealert release (Northwestern University) 16 December 2008: Virus races through healthy genital skin to reach immune cells in just four hours.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>Deborah</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Statement</dc:subject>                <dc:date>2008-12-17T12:53:00Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.mmci-communications.org/media-and-news/news-archives/2008/november-2008/news_item.2008-11-07.1262148442">        <title>STATEMENT: UK calls for new drive on HIV research</title>        <link>http://www.mmci-communications.org/media-and-news/news-archives/2008/november-2008/news_item.2008-11-07.1262148442</link>        <description>United Kingdom (DFID News) 4 November 2008: The HIV epidemic is set to spiral out of control unless new ways to prevent infection are discovered, Development Minister Gareth Thomas warned today.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>Deborah</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Funding</dc:subject>                    <dc:subject>DFID</dc:subject>                    <dc:subject>Statement</dc:subject>                <dc:date>2008-11-25T08:00:08Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.mmci-communications.org/media-and-news/news-archives/2008/september-2008/statement-conrad-receives-100-million-from-usaid-for-microbicide-development.html">        <title>STATEMENT: CONRAD Receives $100 million from USAID for Microbicide Development</title>        <link>http://www.mmci-communications.org/media-and-news/news-archives/2008/september-2008/statement-conrad-receives-100-million-from-usaid-for-microbicide-development.html</link>        <description>Arlington, VA (CONRAD) 8 September 2008: The CONRAD Program of the Eastern Virginia Medical School today announced that it has received a $100 million award from the US Agency for International Development (USAID) to continue its development work on microbicides. To date, USAID has awarded a total of $160 million to CONRAD for microbicide research.
</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>Deborah</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>CONRAD</dc:subject>                    <dc:subject>Statement</dc:subject>                <dc:date>2008-11-28T07:52:08Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.mmci-communications.org/media-and-news/news-archives/2008/august-2008/news_item.2008-11-14.5538548057">        <title>STATEMENT: Spain Contributes €1.5 Million to Global Efforts to Help Women Protect Themselves from HIV</title>        <link>http://www.mmci-communications.org/media-and-news/news-archives/2008/august-2008/news_item.2008-11-14.5538548057</link>        <description>MEXICO CITY (IPM and Planeta Salud) 4 August 2008: The government of Spain has announced its first contribution to the international effort to develop a microbicide that would offer women a promising new option to protect themselves from HIV infection.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>Deborah</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Funding</dc:subject>                    <dc:subject>Statement</dc:subject>                    <dc:subject>IPM</dc:subject>                <dc:date>2008-11-28T08:10:33Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.mmci-communications.org/media-and-news/news-archives/2008/february-2008/inaugural-omololu-falobi-awards-for-excellence-in-hiv-prevention.html">        <title>STATEMENT: Inaugural Omololu Falobi Awards for Excellence in HIV Prevention</title>        <link>http://www.mmci-communications.org/media-and-news/news-archives/2008/february-2008/inaugural-omololu-falobi-awards-for-excellence-in-hiv-prevention.html</link>        <description>New Delhi, India (Release by AMAG, AVAC, GCM, JAAIDS, NHVMAG, TAM) 24 February 2008: 'Awards Presented at the International Microbicide 2008 Conference Recognize Exceptional Community Advocacy and International Leadership as Critical in Advancing Microbicides Research' </description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>Lori</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Statement</dc:subject>                    <dc:subject>Omololu Falobi</dc:subject>                <dc:date>2008-11-18T12:08:35Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.mmci-communications.org/media-and-news/news-archives/2008/june-2008/trial-is-first-to-see-if-hiv-prevention-gels-are-safe-for-pregnant-women-their-babies.html">        <title>STATEMENT: Trial is first to see if hiv prevention gels are safe for pregnant women, their babies</title>        <link>http://www.mmci-communications.org/media-and-news/news-archives/2008/june-2008/trial-is-first-to-see-if-hiv-prevention-gels-are-safe-for-pregnant-women-their-babies.html</link>        <description>Pittsburgh, PA (Microbicide Trials Network) 12 June 2008: Researchers plan to test microbicides to see if they are safe and effective in pregnant women.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>Lori</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Trial</dc:subject>                    <dc:subject>Statement</dc:subject>                    <dc:subject>Pregnant</dc:subject>                <dc:date>2008-11-28T08:36:59Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.mmci-communications.org/media-and-news/news-archives/2008/may-2008/statement-on-co-enrollment-of-participants-in-caprisa-004-and-hptn-035-in-south-africa.html">        <title>Statement on co-enrollment of participants in CAPRISA 004 and HPTN 035 in South Africa</title>        <link>http://www.mmci-communications.org/media-and-news/news-archives/2008/may-2008/statement-on-co-enrollment-of-participants-in-caprisa-004-and-hptn-035-in-south-africa.html</link>        <description>Open letter by Dr. Sharon Hillier, PI. (Microbicide Trials Network) 5 May 2008.  </description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>Lori</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>MTN</dc:subject>                    <dc:subject>CAPRISA</dc:subject>                    <dc:subject>Statement</dc:subject>                    <dc:subject>Trial</dc:subject>                <dc:date>2008-11-28T08:38:11Z</dc:date>        <dc:type>News Item</dc:type>    </item>




</rdf:RDF>

